Perrigo (PRGO) Share-based Compensation (2013 - 2026)
Perrigo (PRGO) posted quarterly Share-based Compensation of $14.4 million for Q1 2026, up 21.01% year-over-year from $11.9 million in Q1 2025, and up 4700.0% quarter-over-quarter from $300000.0 in Q4 2025.
Perrigo (PRGO) Share-based Compensation (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has reported Share-based Compensation for 14 consecutive years, with $14.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Share-based Compensation rose 21.01% year-over-year to $14.4 million; the TTM figure through Mar 2026 stood at $21.6 million (up 83.05% YoY), while the FY2025 annual figure was $19.1 million, up 23.23% from the prior year.
- Share-based Compensation rose to $14.4 million in Q1 2026 per PRGO's latest filing, from $300000.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $26.3 million in Q2 2022 and bottomed at -$23.6 million in Q3 2024.
- Historically, Share-based Compensation has averaged $10.2 million across 5 years, with a median of $11.9 million in 2025.
- Annual changes were most pronounced in 2023 — Share-based Compensation soared 69.09% — and 2024, when it sank 260.54%.
- Perrigo's Share-based Compensation stood at $8.2 million in 2022, then advanced by 29.27% to $10.6 million in 2023, then sank by 95.28% to $500000.0 in 2024, then sank by 40.0% to $300000.0 in 2025, then soared by 4700.0% to $14.4 million in 2026.
- Business Quant data shows PRGO's Share-based Compensation at $14.4 million in Q1 2026, $300000.0 in Q4 2025, and -$9.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 40.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 26.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 114.12 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 19.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 30.40 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 65.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 7.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Perrigo | 1.91 Bn | 1.51 Bn | 313.90 Mn | 6.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 6.80 Mn |
| Jun 27, 2026 | 6.80 Mn |
| Mar 28, 2026 | 14.40 Mn |
| Mar 28, 2026 | 14.40 Mn |
| Dec 31, 2025 | 300,000.00 |
| Dec 31, 2025 | 300,000.00 |
| Sep 27, 2025 | -9.60 Mn |
| Sep 27, 2025 | -9.60 Mn |
| Jun 28, 2025 | 16.50 Mn |
| Jun 28, 2025 | 16.50 Mn |
| Mar 29, 2025 | 11.90 Mn |
| Mar 29, 2025 | 11.90 Mn |
| Dec 31, 2024 | 500,000.00 |
| Dec 31, 2024 | 500,000.00 |
| Sep 28, 2024 | -23.60 Mn |
| Sep 28, 2024 | -23.60 Mn |
| Jun 29, 2024 | 23.00 Mn |
| Jun 29, 2024 | 23.00 Mn |
| Mar 30, 2024 | 15.60 Mn |
| Mar 30, 2024 | 15.60 Mn |